Risks and limits of Abnehmspritze Test

The so-called 'weight loss injection test' (e.g., for GLP-1 receptor agonists) is often marketed as a DNA or biomarker test to predict individual response or side effects. However, scientific evidence is weak: no validated genetic markers currently allow reliable prediction of efficacy or adverse events for these drugs. Most tests examine only a few variants (e.g., in GLP1R) with small effect sizes, easily outweighed by diet, exercise, and gut microbiome. A key risk is that users may skip medical supervision based on a 'favorable' result, ignoring serious risks like pancreatitis, gallbladder issues, or delayed gastric emptying. These tests are not clinically validated for dosing or safety screening. MyBody-X does not offer such a test; commercial versions are largely marketing-driven. Conclusion: evidence is insufficient; avoid self-medication and consult a physician for proper indication and monitoring.